首页 产品目录 分子砌块 按官能团 氨基酸 (6R,7R)-7-((R)-2-amino-2-(4-hydroxyphenyl)acetamido)-8-oxo-3-(prop-1-en-1-yl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

(6R,7R)-7-((R)-2-amino-2-(4-hydroxyphenyl)acetamido)-8-oxo-3-(prop-1-en-1-yl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

(6R,7R)-7-((R)-2-amino-2-(4-hydroxyphenyl)acetamido)-8-oxo-3-(prop-1-en-1-yl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

产品编号 :
Cas No. :
包装规格 纯度 目录价 会员专享价 库存 数量
1mg 95% 询价
- +
晶智化学产品均仅供科研使用。在任何情况下,我们均不提供用于动物或人体用途的产品或服务。

基础信息

CAS No.

92665-29-7

英文名称

(6R,7R)-7-((R)-2-amino-2-(4-hydroxyphenyl)acetamido)-8-oxo-3-(prop-1-en-1-yl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

别名

CEFPROZIL:(6R,7R)-7-[(2R)-2-AMINO-2-(4-HYDROXYPHENYL)ACETYLAMINO]-8-OXO-3-(1-PRO-PENYL)-5-THIA-1-AZABICYLO[4.2.0]OCT-2-ENE-2-CARBOXYLIC ACID;(6R,7R)-7-[[(2R)-2-Amino-2-(4-hydroxyphenyl)acetyl]amino]-8-oxo-3-(1-propen-1-yl)-5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid;Cefprozile;Cephprozyl;Procef;Prozef;5-Thia-1-azabicyclo4.2.0oct-2-ene-2-carboxylic acid, 7-(2R)-amino(4-hydroxyphenyl)acetylamino-8-oxo-3-(1-propenyl)-, (6R,7R)-;(6R,7R)-7-[(2R)-2-Amino-2-(4-hydroxyphenyl) acetylamino]-8-oxo-3-(1-pro-penyl)-5-thia-1-azabicylo [4.2.0]oct-2-ene-2-carboxylic acid

标准英文名

(6R,7R)-7-((R)-2-amino-2-(4-hydroxyphenyl)acetamido)-8-oxo-3-(prop-1-en-1-yl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

分子式

C18H19N3O5S

分子量

389.43

精确分子量

389.10

SMILES

CC=CC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)[C@H](N)C3=CC=C(O)C=C3)[C@H]2SC1

标准SMILES

CC=CC1CS[C@@H]2[C@H](NC(=O)[C@H](N)C3C=CC(O)=CC=3)C(=O)N2C=1C(O)=O

用途

Cefprozil is a second-generation cephalosporin antibiotic with broad-spectrum antibacterial activity. It is indicated for the treatment of mild to moderate infections caused by susceptible bacteria, including: - Upper respiratory tract infections: - Streptococcus pyogenes pharyngitis/tonsillitis; - Otitis media and acute sinusitis caused by Streptococcus pneumoniae, Haemophilus influenzae (including β-lactamase–producing strains), and Moraxella catarrhalis (including β-lactamase–producing strains). - Lower respiratory tract infections: - Acute bacterial exacerbations of chronic bronchitis and acute bacterial bronchitis caused by S. pneumoniae, H. influenzae (including β-lactamase–producing strains), and M. catarrhalis (including β-lactamase–producing strains). - Skin and skin structure infections: - Uncomplicated skin and skin structure infections caused by Staphylococcus aureus (including penicillinase-producing strains) and Streptococcus pyogenes (note: abscesses usually require surgical drainage). Cefprozil is the first oral cephalosporin approved by the U.S. FDA for the treatment of otitis media and sinusitis in children. It demonstrates potent activity against β-lactamase–producing strains of S. aureus, H. influenzae, and M. catarrhalis, making it suitable for treating infections caused by these resistant organisms. Among oral second-generation cephalosporins, cefprozil exhibits favorable activity against S. pneumoniae and is recommended by the Infectious Diseases Society of America (IDSA) for the treatment of community-acquired pneumonia caused by penicillin-susceptible S. pneumoniae, although this indication has not yet received FDA approval.

InChIKey

WDLWHQDACQUCJR-PBFPGSCMSA-N

安全信息

SureRoute逆合成路线

1.  92665-29-7 逆合成路线 1

—
—
ACMWRG246
92665-29-7
来源: SureRoute

2.  92665-29-7 逆合成路线 2

—
—
ACMWRG246
92665-29-7
来源: SureRoute

3.  92665-29-7 逆合成路线 3

—
—
ACMWRG246
92665-29-7
来源: SureRoute
评论 0
我是晶智Agent,
您的化学小助手